Format

Send to

Choose Destination
Int J Cardiol. 2018 Oct 15;269:298-303. doi: 10.1016/j.ijcard.2018.07.111. Epub 2018 Jul 26.

Intimal disruption in type B aortic intramural hematoma. Does size matter? A systematic review and meta-analysis.

Author information

1
Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona. Electronic address: moral.sergio@yahoo.es.
2
Radiology Department, Centre d'Atenció Primaria Pare Claret, Institut Català de la Salut, Barcelona, Spain.
3
Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
4
Department of Pathology, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona.
5
Cardiology Department, Hospital Universitari Doctor Josep Trueta, CIBER-CV, Girona.
6
Cardiology Department, Hospital General Universitari Vall d'Hebron, CIBER-CV, Barcelona, Spain.

Abstract

BACKGROUND:

Type B intramural hematoma (IMH) is considered a low-risk entity for aortic complications if aortic dilation, containing rupture or clinical instability are absent. However, the development of intimal disruptions (ID), present in >40% of cases, poses an unknown risk.

OBJECTIVES:

To establish which ID characteristics imply a higher risk of aortic complications and, therefore, merit invasive treatment.

METHODS:

A systematic review and a meta-analysis were made following a search in EMBASE, MEDLINE and PsycINFO for articles published between January 1995 and December 2017. The combined endpoint was defined as aortic mortality, invasive treatment for aortic disease and/or increase in maximum aortic diameter ≥55 mm. Lesions with communicating orifice ≤3 mm were defined as tiny ID (TID) and those with >3 mm as focal ID (FID).

RESULTS:

Six studies with 564 participants diagnosed of type B IMH were included. Incidence of ID was 54.3% (306 individuals): 27.7% (156 individuals) initially met TID criteria; however, 13.9% of these (21 of 151 with morphologic evolution) evolved to FID within the first 6 months. Ninety-two cases suffered clinical aorta-related events (16.3%; mean follow-up range: 15-85 months; median: 52 months). Patients with TID had a similar risk of aorta-related events to those without ID (RR = 0.904; 95% CI, 0.335-2.440; P = 0.842; I2 = 42.5%), but lower than those with FID (RR = 0.299; 95% CI, 0.094-0.952; P = 0.041; I2 = 26.9%).

CONCLUSIONS:

Tiny intimal disruption in type B IMH evolution is not related to an increased risk of complications and should not be considered an indication for invasive treatment. However, since 14% of TID evolve to FID within the first 6 months, close follow-up with imaging techniques is advisable.

KEYWORDS:

Aorta; Endovascular treatment; Intimal disruption; Intramural hematoma; Multidetector computed tomography

PMID:
30057168
DOI:
10.1016/j.ijcard.2018.07.111
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center